Skip to content

Atrial Fibrillation Detection Using Garmin Wearable Technology

Atrial Fibrillation Detection Using Garmin Wearable Technology

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03566836
Acronym
GARMIN AF
Enrollment
120
Registered
2018-06-25
Start date
2018-06-19
Completion date
2020-01-31
Last updated
2019-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Smart Watch, Garmin, Wearable, Cardioversion

Brief summary

The purpose of this study is to evaluate the feasibility of detecting atrial fibrillation (AF) in patients with AF using a wearable wrist device/smart watch.

Detailed description

Even though AF is common and associated with increased risk of stroke, quite often it goes undetected until late in the course of the condition. If AF can be detected with simpler tools like a smart watch, it would enable providers to identify patients with AF much earlier in the course of the condition (even before being seen by a physician) and hopefully be able to prevent stroke. This study is being done to identify a technology that can likely identify AF using a smart watch.

Interventions

DEVICEGarmin Smart Watch

Garmin Smart Watch

DEVICEGarmin Chest Band

Garmin Chest Band

Sponsors

Garmin International
CollaboratorINDUSTRY
University of Kansas Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* All patients with AF scheduled to undergo electrical cardioversion at the University of Kansas Health System

Exclusion criteria

* Patients with no detectable PPG * Hemodynamically unstable patients * Patients who cannot give informed consent * Patients with tattoos on the wrists

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificity of Garmin wearable device in detecting AFVisit 1PPG samples collected from Garmin wearable will be evaluated and calculated by Garmin custom

Countries

United States

Contacts

Primary ContactMargana Morgan
mmorgan@kumc.edu913-945-6443

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026